Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Familial non-autoimmune autosomal dominant hyperthyroidism (FNAH) is a rare hyperthyroidism characterized by mild to severe hyperthyroidism, presence of goiter, absence of features of autoimmunity, frequent relapses while on treatment and a positive family history.
Features include always present findings: Increased circulating thyroglobulin concentration, Increased circulating T4 concentration, Increased circulating free T3, and Hyperthyroidism and others. 19 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Lab test results | 5 | Increased circulating thyroglobulin concentration, Increased circulating T4 concentration, Anti-thyroid peroxidase antibody positivity |
TSHR function has not been fully characterized.
Familial hyperthyroidism due to mutations in TSH receptor is associated with mutations in the TSHR gene on chromosome 14.
Genetic testing for TSHR is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 12 always present features.
Estimated prevalence: Unknown (Unknown prevalence).
No clinical trials have been registered for familial hyperthyroidism due to mutations in TSH receptor.
10 publications have been identified in PubMed for familial hyperthyroidism due to mutations in TSH receptor. Research spans Case Report / Case Series (60%), Review / Meta-Analysis (30%), and Basic Science / Preclinical (10%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 6 | 60% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 5:50 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Hormones | 4 | Anti-thyroid peroxidase antibody positivity, Hyperthyroidism, Decreased thyroid-stimulating hormone level |
Brain and nerves | 2 | Delayed speech and language development, Intellectual disability |
Heart and blood vessels | 1 | Tachycardia |
Bones and joints | 1 | Accelerated skeletal maturation |
Research summaries |
3 |
30% |
Laboratory research | 1 | 10% |
Rumińska M (2026). [PMID: 41884215](https://pubmed.ncbi.nlm.nih.gov/41884215/). *Front Endocrinol (Lausanne)*. [Case Report / Case Series]
Yamichannaiah C (2025). [PMID: 40470728](https://pubmed.ncbi.nlm.nih.gov/40470728/). *Clinical endocrinology*. [Review / Meta-Analysis]
Charbonne G (2025). [PMID: 40201472](https://pubmed.ncbi.nlm.nih.gov/40201472/). *AACE clinical case reports*. [Case Report / Case Series]
Torrey AC (2025). [PMID: 41064600](https://pubmed.ncbi.nlm.nih.gov/41064600/). *Case reports in endocrinology*. [Case Report / Case Series]
Shimura K (2025). [PMID: 39987906](https://pubmed.ncbi.nlm.nih.gov/39987906/). *Hormone research in paediatrics*. [Case Report / Case Series]
Xu W (2025). [PMID: 41216432](https://pubmed.ncbi.nlm.nih.gov/41216432/). *Translational pediatrics*. [Case Report / Case Series]
Shima H (2025). [PMID: 40494332](https://pubmed.ncbi.nlm.nih.gov/40494332/). *Hormone research in paediatrics*. [Basic Science / Preclinical]
Mooij CF (2025). [PMID: 39189533](https://pubmed.ncbi.nlm.nih.gov/39189533/). *The Journal of clinical endocrinology and metabolism*. [Review / Meta-Analysis]
Takahashi S (2024). [PMID: 39301178](https://pubmed.ncbi.nlm.nih.gov/39301178/). *JCEM case reports*. [Case Report / Case Series]
Zhang Y (2024). [PMID: 39269788](https://pubmed.ncbi.nlm.nih.gov/39269788/). *J Med Chem*. [Review / Meta-Analysis]